StemMed Competitors and Similar CompaniesClear all

Moleculin Biotech's competitors and similar companies include Eleison Pharmaceuticals, NiKang Therapeutics and Elevation Oncology.
Moleculin Biotech
Moleculin Biotech
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
Eleison Pharmaceuticals
Eleison Pharmaceuticals
Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.
NiKang Therapeutics
NiKang Therapeutics
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
Elevation Oncology
Elevation Oncology
Elevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers.
Founding Date
Founding Date
2006
Founding Date
2008
Founding Date
2017
Founding Date
2019
Type
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Houston, US HQ
Locations
Princeton, US HQ
Locations
Wilmington, US HQ
Locations
New York, US HQ
Employees
Employees
176% decrease
Employees
12
Employees
403% increase
Employees
8
Valuation ($)
Valuation ($)
7.5 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
35.1 m

Financial

Net income
Net income
($33.6m) (FY, 2025)
Net income
N/A
Net income
N/A
Net income
($44.5m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 491k
Total funding raised
N/A
Total funding raised
$ 200m
Total funding raised
$ 97.5m
For sources of this data, please see the company profile

View Company Profiles

Eleison Pharmaceuticals
HQ
Princeton, US
Employees
12

Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.

View company
NiKang Therapeutics
HQ
Wilmington, US
Employees
40↑ 3% increase

NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.

View company
Elevation Oncology
HQ
New York, US
Employees
8

Elevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers.

View company